Press | Goodwork

WHO Ruling

RULING BY WORLD HEALTH ORGANIZATION DELIGHTS DOCTORS. Itraconazole, voriconazole and natamycin 5% ophthalmic preparation ruled as ‘essential antifungals’. GAFFI (Global Action Fund for Fungal Infections) says today’s announcement that three drugs capable of reducing deaths in hundreds of thousands of people worldwide have been given essential medicines status is a Red Letter Day in the…

Read More

Candida auris

New evidence to help fight the yeast superbug that experts say is a real threat to our global health. UK scientists are reporting for the first time that a deadly form of a drug resistant yeast that has caused hospital outbreaks and deaths across the world is sensitive to the disinfectant most widely used to…

Read More

GAFFI Report

New model for saving millions of lives from fungal disease being implemented. GAFFI annual report on fungal diseases: Highlihgts progress but scale of global work still to be done.   GAFFI (Global Action Fund for Fungal Infections) has today published its third annual report demonstrating progress made in its mission to reduce illness and death associated…

Read More

The burden of fungal disease

New evidence to show the scale of the problem across the globe.  Estimates never before attempted, show the number of people affected by serious fungal diseases in 14 of the worst affected countries across the globe have just been published. Experts believe they give a stark reminder of the huge disconnect between the lack of…

Read More

Centre of excellence

IMPORTANT HONOUR FOR UNIVERSITY HOSPITAL OF SOUTH MANCHESTER AND THOSE DOCTORS AND SCIENTISTS FIGHTING TO HELP PATIENTS WITH FUNGAL DISEASES. The University Hospital of South Manchester (UHSM) is to become the first hospital in the UK and Europe to be recognised as a centre of excellence for the diagnosis and treatment of aspergillosis and other…

Read More

Essential antifungal medicines

Itraconazole, voriconazole and natamycin 5% ophthalmic preparation proposed as ‘essential antifungal medicines’ to reduce deaths and blindness. GAFFI has applied for itraconazole (capsules and oral suspension), voriconazole (capsules and intravenous solution) and natamycin 5% ophthalmic solution to be placed on the World Health Organization (WHO) Essential Medicine List (EML), in collaboration with colleagues from the…

Read More

Fungal Asthma

LIVING WITH UK BURDEN OF FUNGAL ASTHMA GREATLY EXCEEDS PRIOR ESTIMATES NEW STUDY WARNS. Experts are warning of a significant increase in the number of people in the UK who are living with invasive and serious fungal diseases that affect the lungs, bloodstream and brain and can sometimes lead to death. While invasive fungal infections…

Read More

E-Learning

Manchester first as e-learning course in fungal microscopy is launched worldwide to help save lives Scientists estimate that of the 5 million fungus species on Earth around 600 cause disease in humans. It is a challenge to diagnose a serious fungal infection in real time and this course is aimed at teaching a rapid method of diagnosis. Experts in Manchester have now developed the…

Read More

Millions Deprived

MILLIONS DEPRIVED OF LIFE SAVING ANTIFUNGAL MEDICINES. New report highlights lack of supply. The world is in the grip of a global crisis that kills the equivalent of the populations of Philadelphia, Kampala or Prague – around 1.6 million each year. A new report published today* in the esteemed Journal of Antimicrobial Chemotherapy, documents how…

Read More

Antibiotic Guardian Awards 2016

MANCHESTER HOSPITAL TEAM SHORTLISTED FOR IMPORTANT AWARD. The work of the Infectious Diseases team at Wythenshawe Hospital in reducing deaths by tackling misuse of antifungals has been shortlisted for a new Government award.  The antifungal stewardship programme at the hospital has been developed over the past seven years to improve patient outcomes by updating and…

Read More

Open

Subscribe to our latest news ...